Osella A R, Misciagna G, Guerra V M, Chiloiro M, Cuppone R, Cavallini A, Di Leo A
Laboratories of Epidemiology and Biostatistics, Medical Research Institute IRCCS Saverio De Bellis Castellana Grotte, Italy.
Int J Epidemiol. 2000 Oct;29(5):922-7. doi: 10.1093/ije/29.5.922.
Hepatitis C virus (HCV) is a common cause of chronic liver diseases but the degree to which these diseases contribute to liver-related mortality is not well established. The aim of this study was to estimate the absolute and relative effects of HCV infection on liver-related mortality.
A population random sample of 2472 subjects aged > or = 30 years was enrolled and followed up from 1985 to 1996. At enrollment, a structured interview and a clinical evaluation were performed. Serum samples were tested using HCV ELISA and RIBA HCV. Outcomes were overall and liver-related mortality and tracing procedures included review of office and hospital records, death certificates, and interviews with general practitioners, attending hospital and next of kin. Statistical analysis was performed using Poisson and binomial prospective data regression.
Crude overall and liver-related mortality rates were 7.66 (95% CI : 6.68-8.79) and 0.9 (95% CI : 0.3-2.2) per 10(3) person-years, respectively. For HCV infection effect, incidence rate ratio and difference (per 10(3) person-year), risk ratio and difference were 27.5 (95% CI : 6.5-115.6), 4 (95% CI : 3-7), 33.1 (95% CI : 7.8- 139.3) and 0.06 (95% CI : 0.04-0.08), respectively; all measures were adjusted for age at death, sex and daily alcohol intake.
The results show a strong relative but weak absolute effect of HCV infection on liver-related mortality in the 10-year period considered. Poisson and binomial models are virtually equivalent, but the choice of the summarizing measure of effect may have a different impact on health policy.
丙型肝炎病毒(HCV)是慢性肝病的常见病因,但这些疾病导致肝脏相关死亡率的程度尚未完全明确。本研究的目的是评估HCV感染对肝脏相关死亡率的绝对和相对影响。
选取年龄≥30岁的2472名受试者作为人群随机样本,于1985年至1996年进行随访。入组时,进行结构化访谈和临床评估。血清样本采用HCV ELISA和RIBA HCV检测。观察指标为全因死亡率和肝脏相关死亡率,追踪程序包括查阅门诊和医院记录、死亡证明,并与全科医生、主治医院及近亲进行访谈。采用泊松和二项式前瞻性数据回归进行统计分析。
粗全因死亡率和肝脏相关死亡率分别为每10³人年7.66(95%CI:6.68 - 8.79)和0.9(95%CI:0.3 - 2.2)。对于HCV感染效应,发病率比和差值(每10³人年)、风险比和差值分别为27.5(95%CI:6.5 - 115.6)、4(95%CI:3 - 7)、33.1(95%CI:7.8 - 139.3)和0.06(95%CI:0.04 - 0.08);所有指标均根据死亡年龄、性别和每日酒精摄入量进行了调整。
结果显示,在所考虑的10年期间,HCV感染对肝脏相关死亡率有较强的相对影响,但绝对影响较弱。泊松模型和二项式模型基本等效,但效应汇总指标的选择可能对卫生政策产生不同影响。